Literature DB >> 20145923

Palliative resection in noncurative gastric cancer patients.

Kuo-Hung Huang1, Chew-Wun Wu, Wen-Liang Fang, Jen-Hao Chen, Su-Shun Lo, Ruei-Fang Wang, Anna Fen-Yau Li.   

Abstract

BACKGROUND: Palliative resection for noncurable gastric cancer remains controversial, especially in the elderly. This retrospective study was designed to elucidate the clinicopathological factors and operative outcome in patients undergoing palliative gastric resection.
METHODS: From January 1988 to December 2008, 365 patients received palliative gastrectomy while 151 underwent exploratory laparotomy or gastrojejunostomy for noncurative gastric cancer at the Department of Surgery, Taipei Veterans General Hospital. Among the 365 patients, 182 patients (Group A) were aged 70 or less and 183 patients (Group B) were older than 70 years of age. Clinicopathological characteristics and surgical morbidity and mortality were analyzed.
RESULTS: The overall survival of patients who underwent resection was 10.2 months and that of patients without resection 4.48 months (p < 0.001). Compared to Group B, Group A patients were predominantly female (p < 0.001), had more advanced Borrmann-type tumors (p = 0.004), more diffuse type of Lauren classification (p < 0.001), and poorer cell differentiation (p < 0.001). The median overall survival was 10.5 months in Group A and 9.7 months in Group B (p = 0.854). The surgical morbidity was significant higher if the patients had comorbidity (p = 0.028). Both surgical morbidity (13.8% vs. 26.8%, p = 0.028) and mortality (0.5% vs. 6.0%, p < 0.0001) were significantly higher in Group B.
CONCLUSIONS: Gastric cancer is less aggressive in the elderly. Palliative gastrectomy can be performed in both younger and older patients, but younger patients tolerate surgery better. More attention should be paid to the perioperative care of the elderly.

Entities:  

Mesh:

Year:  2010        PMID: 20145923     DOI: 10.1007/s00268-010-0467-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

1.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

2.  Is there a role for palliative gastrectomy in patients with stage IV gastric cancer?

Authors:  Reza F Saidi; Stephen G ReMine; Paul S Dudrick; Nader N Hanna
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

3.  Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy.

Authors:  H C Jeung; S Y Rha; W I Jang; S H Noh; H C Chung
Journal:  Br J Surg       Date:  2002-04       Impact factor: 6.939

4.  Palliative gastrectomy in advanced gastric cancer: is it worthwhile?

Authors:  Inian Samarasam; B Sudhakar Chandran; V Sitaram; Benjamin Perakath; Aravindan Nair; George Mathew
Journal:  ANZ J Surg       Date:  2006 Jan-Feb       Impact factor: 1.872

Review 5.  HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target.

Authors:  C Gravalos; A Jimeno
Journal:  Ann Oncol       Date:  2008-04-25       Impact factor: 32.976

Review 6.  Palliative management of gastric cancer.

Authors:  Steven C Cunningham; Richard D Schulick
Journal:  Surg Oncol       Date:  2007-09-18       Impact factor: 3.279

7.  Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Authors:  David Cunningham; Naureen Starling; Sheela Rao; Timothy Iveson; Marianne Nicolson; Fareeda Coxon; Gary Middleton; Francis Daniel; Jacqueline Oates; Andrew Richard Norman
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

8.  Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.

Authors:  A F C Okines; A R Norman; P McCloud; Y-K Kang; D Cunningham
Journal:  Ann Oncol       Date:  2009-05-27       Impact factor: 32.976

9.  Palliative gastrectomy and chemotherapy for stage IV gastric cancer.

Authors:  Sheng-Zhang Lin; Hong-Fei Tong; Tao You; Yao-Jun Yu; Wei-Jun Wu; Cong Chen; Wei Zhang; Bing Ye; Chun-Ming Li; Zhi-Qiang Zhen; Jia-Rong Xu; Jun-Liang Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-05       Impact factor: 4.553

10.  Palliative surgery for advanced stage (stage IV) gastric adenocarcinoma.

Authors:  Okay Nazli; Ismail Yaman; Tuğrul Tansuğ; Ali Serdar Işgüder; Ali Dogan Bozdag; Hakan Bölükbaşi
Journal:  Hepatogastroenterology       Date:  2007 Jan-Feb
View more
  14 in total

Review 1.  Gastric cancer surgery: an American perspective on the current options and standards.

Authors:  Joyce Wong; Patrick Jackson
Journal:  Curr Treat Options Oncol       Date:  2011-03

Review 2.  Non-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature.

Authors:  Yves Dittmar; Falk Rauchfuss; Max Goetz; Karin Jandt; Hubert Scheuerlein; Michael Heise; Utz Settmacher
Journal:  Langenbecks Arch Surg       Date:  2012-02-04       Impact factor: 3.445

3.  Staging and surgical approaches in gastric cancer: a clinical practice guideline.

Authors:  N Coburn; R Cosby; L Klein; G Knight; R Malthaner; J Mamazza; C D Mercer; J Ringash
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

4.  Surgical impact on gastric cancer with locoregional invasion.

Authors:  Kuan-Kai Lai; Wen-Liang Fang; Chew-Wun Wu; Kuo-Hung Huang; Jen-Hao Chen; Su-Shun Lo; Anna Fen-Yau Li
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

5.  Preoperative CA 125 is significant indicator of curative resection in gastric cancer patients.

Authors:  Dae Hoon Kim; Hyo Yung Yun; Dong Hee Ryu; Hye-Suk Han; Joung-Ho Han; Soon Man Yoon; Sei Jin Youn
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

6.  Surgical and Survival Outcome Following Truly Palliative Gastrectomy in Patients with Incurable Gastric Cancer.

Authors:  Masanori Tokunaga; Rie Makuuchi; Yuichiro Miki; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

Review 7.  Surgical palliation of gastric outlet obstruction in advanced malignancy.

Authors:  Brittany A Potz; Thomas J Miner
Journal:  World J Gastrointest Surg       Date:  2016-08-27

8.  Gastrectomy for Metastatic Gastric Cancer: a 15-year Experience from a Developing Country.

Authors:  Mushegh А Sahakyan; Artak Gabrielyan; Davit L Aghayan; Shushan Yesayan; Hmayak Petrosyan; Аlina Chobanyan; Airazat M Kazaryan; Artur M Sahakyan
Journal:  Indian J Surg Oncol       Date:  2019-05-29

Review 9.  Surgical considerations in the treatment of gastric cancer.

Authors:  Andrew M Blakely; Thomas J Miner
Journal:  Gastroenterol Clin North Am       Date:  2013-03-01       Impact factor: 3.806

10.  Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.

Authors:  Ziyu Li; Biao Fan; Fei Shan; Lei Tang; Zhaode Bu; Aiwen Wu; Lianhai Zhang; Xiaojiang Wu; Xianglong Zong; Shuangxi Li; Hui Ren; Jiafu Ji
Journal:  World J Surg Oncol       Date:  2015-07-01       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.